Abstract
1. Crude globulin from more than 1,000 liters of citrated bovine plasma has been used in developing a procedure for moderately large scale separation of clotting factors. Fraction A, prothrombin, kinase, and thrombin fractions were prepared. Fraction A contained both kinase and accessory thromboplastin, the latter predominating when fraction A was diluted. 2. When prothrombin was activated by kinase, the rate of thrombin production was enhanced by the addition of platelets, or brain lipid, or dilute fraction A. These accessory thromboplastins caused this acceleration only when calcium chloride was added. Even with calcium, they were not effective unless kinase was present. 3. In contrast, the action of kinase was not entirely dependent on either ionic calcium or accessory thromboplastin. The concentrated kinase fraction activated prothrombin in the presence of excess oxalate. Although kinase often contaminates highly purified thrombins, it is probably distinct from thrombin. The ratio of kinase to thrombin was 100 times as great in the kinase fraction as in the thrombin fraction. 4. The kinase fraction, diluted 45,000-fold, to protein-nitrogen concentrations as low as 0.02 microgram per ml., accelerated the conversion of crude prokinase in three-stage tests. 5. The findings are consistent with the following concept of the basic enzymatic mechanism: See PDF for Structure It is now added that calcium and accessory thromboplastin exert their effects by impinging on the basic mechanism, in a chemically secondary or indirect manner.
Full Text
The Full Text of this article is available as a PDF (1.1 MB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Alexander B., de Vries A., Goldstein R., Landwehr G. A Prothrombin Conversion Accelerator in Serum. Science. 1949 May 27;109(2839):545–545. doi: 10.1126/science.109.2839.545. [DOI] [PubMed] [Google Scholar]
- Dale H. H., Walpole G. S. Some Experiments on Factors Concerned in the Formation of Thrombin. Biochem J. 1916 Oct;10(3):331–362. doi: 10.1042/bj0100331. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HILLER A., PLAZIN J., VAN SLYKE D. D. A study of conditions for Kjeldahl determination of nitrogen in proteins; description of methods with mercury as catalyst, and titrimetric and gasometric measurements of the ammonia formed. J Biol Chem. 1948 Dec;176(3):1401–1420. [PubMed] [Google Scholar]
- MILSTONE J. H. A highly active material that promotes conversion of prothrombokinase complex. Proc Soc Exp Biol Med. 1949 Nov;72(2):315–315. doi: 10.3181/00379727-72-17419. [DOI] [PubMed] [Google Scholar]
- MILSTONE J. H. The problem of the lipoid thromboplastins. Yale J Biol Med. 1950 Jul;22(6):675–687. [PMC free article] [PubMed] [Google Scholar]
- Northrop J. H. PURIFICATION AND CRYSTALLIZATION OF DIPHTHERIA ANTITOXIN. J Gen Physiol. 1942 Jan 20;25(3):465–485. doi: 10.1085/jgp.25.3.465. [DOI] [PMC free article] [PubMed] [Google Scholar]
- RATNOFF O. D., HARTMANN R. C., CONLEY C. L. Studies on a proteolytic enzyme in human plasma; the relationship between the proteolytic activity of plasma and blood coagulation. J Exp Med. 1950 Feb;91(2):123–133. doi: 10.1084/jem.91.2.123. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SEEGERS W. H., McCLAUGHRY R. I., FAHEY J. L. Some properties of purified prothrombin and its activation with sodium citrate. Blood. 1950 May;5(5):421–433. [PubMed] [Google Scholar]
- TRAVIS B. L., FERGUSON J. H. Proteolytic enzymes and platelets in relation to blood coagulation. J Clin Invest. 1951 Jan;30(1):112–123. doi: 10.1172/JCI102411. [DOI] [PMC free article] [PubMed] [Google Scholar]